In obese women (a = 16) at their usual weight, fasting adipose tissue lipoprotein lipase (LPL) activity, obtained by elution with serum and heparin at 40 and 370C, was inversely correlated to plasma estradiol levels (r = -0.724; P = 0.002) and (r = -0.641; P = 0.010), respectively. Furthermore, fasting postheparin plasma LPL activity during a heparin infusion, showed an even stronger inverse correlation to plasma estradiol when measured at 60 min (r = -0.815; P < 0.001). None of the above parameters was correlated to the body mass index.
Introduction
Although men and women are clearly different regarding circulating plasma lipoprotein concentrations (1) and body fat distribution (2) the underlying mechanisms are incompletely understood. In both these aspects of lipid metabolism, lipoprotein lipase (LPL)' probably has a critical role. The enzyme hydrolyzes the triglyceride transported in very low density lipoproteins (VLDL) and chylomicrons thereby making their triglyceride fatty acids available for uptake in various tissues including adipose tissue (3) . Thus the enzyme participates in the metabolism of major lipoprotein species as well as in the regulation of fat cell size.
The concentration of most of the hormones reported to either stimulate (4) (5) (6) (7) (8) (9) or inhibit (5, 10-12) rat adipose tissue LPL activity, are the same in both sexes. Sex steroids on the other hand account for many differences between the sexes, making it likely that these hormones also account for sex differences in LPL regulation. Convincing evidence for their effect on LPL has so far mainly been obtained in the rat. Thus, estradiol reduces adipose tissue LPL activity in both intact and gonadectomized animals (13) (14) (15) (16) (17) (18) (19) (20) , while progestin, only affecting female adipose tissue (16) , counteracts the estrogen effects on LPL (16) (17) . Androgen inhibition of adipose tissue LPL appears to result from estradiol formed by aromatization rather than from a direct effect (21) .
In man, some studies have failed to demonstrate effects of oral estrogen on either adipose tissue (22) or postheparin plasma LPL (22) (23) (24) (25) , while others have reported that oral estrogen inhibits postheparin plasma LPL in postmenopausal women (26, 27) . Oral or percutaneous progestin alone (24, 28, 29) , or in combination with estrogen (30) , may enhance LPL activity in adipose tissue (28, 29) and postheparin plasma (24) , respectively, while no effect on postheparin plasma LPL has been observed with low dose oral contraceptive (31) and anabolic steroid (31, 32) .
Only a few human studies have explored the relationship between endogenous sex steroid levels in plasma and LPL activity. Thus no relationship has been demonstrated between either estradiol and postheparin plasma LPL (33) or estrone and adipose tissue LPL activity (28). Correlations between testosterone levels and LPL have been reported to be negative for adipose tissue (33) , and either positive (28, 34) or absent (33) , for postheparin plasma.
In summary, available data regarding sex steroid effects on adipose tissue and postheparin plasma LPL activity in man are contradictory and have failed to reproduce the strong and consistent effects observed in the rat. However, endogenous sex steroid levels in plasma were measured only in a few ofthe human studies.
The present study was undertaken in an attempt to resolve some of the discrepancies and to explore the role of endogenous sex steroids in the regulation of adipose tissue and postheparin plasma LPL in women. Precise and specific assays for LPL were employed. In addition, postheparin plasma lipase activities were determined after a standard bolus heparin injection and during prolonged heparin infusion, to take into account the possibility that there are differences in the kinetics of LPL release from different tissues. (Table I ) and one on low-dose estrogen replacement (Table IV) , were taken off their usual medications during the study. Other data from these subjects have been reported previously (35) . Clinical chemistry. Fasting morning blood samples were obtained after the initial weight adjustment period had been completed. An automated chemical profile and assays for thyroxine, T3-resin uptake, and thyrotropin were done in the clinical laboratory at the University of Washington Hospital. Radioimmunoassays for total serum estrone (36) and testosterone (37) as well as determinations offree testosterone by equilibrium dialysis (38) were performed by Nichols Institute, San Juan Capistrano, CA. Total serum estradiol was measured by a kit (unpublished observations) from Pantex Laboratories, Santa Monica, CA. In menstruating subjects, these samples were obtained on the fourteenth day from the start ofthe last menstrual period. Plasma lipid determinations were performed at the Northwest Lipid Research Clinic following a standard protocol (39) .
Lipoprotein lipase. Fasting LPL activity in gluteal adipose tissue needle biopsies from below the postero-lateral iliac crest, and postheparin plasma was determined as described previously (35, 40) . Before assay, the enzyme was recovered from the adipose tissue by elution with serum and heparin at 40 and 370C, and by extraction with deter- cally active enzyme than detergent-extracted enzyme, which measures the total LPL activity in the tissue (35) . Adipose tissue LPL activity was related to either wet tissue weight or cell number after determination of average fat cell size (41) . Postheparin plasma LPL activity was calculated as the fraction of total lipolytic activity that was inhibited by an antiserum to LPL whereas the noninhibited fraction was taken as hepatic triglyceride lipase activity (42). Fasting activity was measured 10 min after the injection of heparin (60 U/kg) as well as at several time points during a high-dose 6-h heparin infusion (35, 43) . Postprandial postheparin plasma activity was measured by injecting heparin (60 U/kg) 120 min after receiving the first feeding of the day and plasma was sampled 10 min after the injection. Data analysis. An AT&T Personal Computer 6300 equipped with the SPSS/PC+ statistical software (SPSS Inc., Chicago, IL) and SigmaPlot (version 3.0) scientific graph software (Jandel Scientific, Sausalito, CA) was used for statistical computations and production of graphs.
Results
Characterization of study population. Anthropometric measures and results of laboratory screening are shown in Table I . None of the subjects had diabetes, two had hyperlipidemia, two had treated hypothyroidism and one had borderline hypothyroidism (Table I ). In addition, four subjects were postmenopausal and two had oligomenorrhea (Table IV) . The results of LPL determinations in adipose tissue and postheparin plasma as well as plasma sex steroid levels are displayed in Tables II-IV, respectively. Relationship between LPL activity and plasma estrogen levels. The correlation matrix displayed in Table V demonstrates that plasma estradiol but not estrone levels showed significant negative correlations with adipose tissue as well as fasting postheparin plasma LPL activity. Only adipose tissue LPL activity eluted at either 4°C or 37°C and expressed per unit weight, showed a significant correlation (Figs. 1 A and 2) . The LPL activity in postheparin plasma sampled at 10, 30, and 60 min after the start of a heparin infusion showed significant negative correlations at all three time points (Table V) . The strongest and most significant was the correlation between fasting 60 min postheparin plasma LPL activity and plasma estradiol (Fig. 3 A) . Since the relationships in Figs. 1 A and 3 A appear to be nonlinear, the data were also plotted with a logarithmic scale on the abscissa ( Fig. 1 B and 3 B) . This maneuver improved the correlations from r = -0.724 (P = 0.002; n = 15) and r = -0.815 (P = 0.0002; n = 15) to r = -0.781 (P = 0.0006) and r = -0.860 (P = 0.0000), respectively. There were no significant correlations between degree of obesity, measured as the body mass index, and either of the above parameters of LPL activity or estradiol levels (data not shown).
Relationship between LPL activity and plasma androgen levels. A strong positive correlation was demonstrated between postprandial LPL activity in 10 min postheparin plasma and total as well as free plasma testosterone (Table V; Fig. 4 ). The postprandial LPL activity in 10 min postheparin plasma was significantly lower than the fasting activity (Table III) and the difference was strongly correlated to fasting adipose tissue LPL activity eluted at 370C and expressed per unit weight (r -0.713; P = 0.004; n = 14). Thus, feeding may have decreased the contribution from the adipose tissue to the postheparin plasma activity and thereby increased the proportion of en- zyme from other sites allowing a previously masked correlation to emerge.
There were no significant correlations between the body mass index and either the postprandial 10 min postheparin plasma enzyme or total and free testosterone levels (data not shown).
Discussion
The strong negative statistical correlations in women between plasma estradiol levels and LPL activity in both adipose tissue and postheparin plasma (35) . It would therefore seem plausible that the strong negative correlations between postheparin plasma LPL and estradiol (Table V) skeletal muscle LPL activity by estrogen (18) . Other experiments, however, have demonstrated the opposite effect (15) . The noticeable correlation between postheparin plasma LPL and estrogen therefore remains to be fully explained.
Adipose tissue LPL activity from the gluteal site, also employed in the present study, is similar to that from the femoral site (46) . In menstruating women, the femoral site has higher LPL activity than tissue from the abdominal site and only LPL from the former site is responsive to the hormonal changes of pregnancy and lactation (47) . After the menopause, however, abdominal and femoral adipose tissue have similar LPL levels (30) . The inverse correlation between gluteal adipose tissue LPL and estradiol suggests that this tissue site also is similar to femoral adipose tissue with regard to hormone responsiveness.
It should be noted that only the adipose tissue LPL recovered by elution, showed significant correlations with estradiol, while detergent-extracted enzyme did not. Since the former parameters presumably represent extracellular enzyme better than the latter (35) , it might be argued that a putative direct effect of estradiol on the tissue could involve inhibition of enzyme secretion, stimulation of uptake and degradation, or removal of extracellular binding sites.
The population studied was heterogeneous in several respects. Although seven of the sixteen women did not have regular periods (Table IV) , it was expected that these subjects would not pose a sampling problem since their estrogen levels could be expected to fluctuate less than in menstruating females. The one subject (No. 7) who had undergone hysterectomy would most likely be postmenopausal given her age (Table I ) and estrogen level (Table IV) Heterogeneity of the study population was particularly apparent for age and degree of obesity (Table I) . Nevertheless, the observed correlations should still be valid unless age and obesity were confounding variables. Since the subjects with the lowest estradiol levels were older than those with higher levels (Tables I and IV) , it may be argued that age was a confounding variable. However, the correlations between age and adipose tissue LPL eluted at 40C (r = 0.643; P = 0.007; n = 16), at 370C (r = 0.567; P = 0.022; n = 16), and 60 min postheparin plasma LPL (r = 0.670; P = 0.005; n = 16) were all weaker than the corresponding correlations with estradiol (Figs. 1 A, 2 , and 3 A, respectively). Moreover, age was not significantly correlated to estradiol (r = -0.502; P = 0.057; n = 15). Finally, previous animal data have provided convincing evidence for inhibition of adipose tissue LPL by estradiol (see Introduction). The present data, interpreted in the latter context, therefore suggest that estradiol also inhibits adipose tissue LPL in man. It cannot be excluded, however, that age may have a minor effect on LPL, independent of estradiol.
Why then, have several previous human studies with two exceptions (26, 27) not found this striking correlation? There are at least two factors that alone or in combination conceivably could explain this discrepancy.
First, the likelihood of detecting an inhibition by exogenous estrogen would be the greatest in the postmenopausal female who has low endogenous estrogen levels and high lipase activity. Indeed, studies in which such effects have been reported were carried out in postmenopausal subjects (26) (27) . On the other hand, the administration of pure estrogen or birth control pills to menstruating women with moderate to high endogenous estrogen levels is likely not to alter total estrogenic activity in plasma due to suppression of ovarian production. Furthermore, the inhibitory effect of estradiol on adipose tissue LPL eluted at 4VC and 60 min postheparin plasma LPL, appears to reach a plateau at estradiol concentrations in the high normal range (Figs. 1 A, and 3 A) where all the cases have regular menstrual periods (Table IV) . As expected, effects of exogenous estrogen on LPL have not been observed in menstruating women (23, 31) .
Second, the sampling time is important in order to obtain a postheparin plasma fraction that shows a strong correlation with adipose tissue LPL activity. While most earlier studies have used postheparin plasma samples obtained at 10 to 15 min after a heparin injection, it was recently demonstrated that samples obtained 60 min after the start of a continuous heparin infusion shows the best correlation with the adipose tissue enzyme (35) .
The absence of any relationship between degree of obesity and LPL activity expressed per unit weight of adipose tissue (see Results) has been reported previously in men (49). Although all the subjects were studied at their usual weight and in the eucaloric state, the difference between the highest and lowest LPL activity in adipose tissue measured by the different parameters varied from two-to severalfold (Table II) . It may be surmised that these differences could reflect the different propensities for rate ofweight gain should the caloric intake be increased above the level for weight maintenance.
The strong positive correlation between plasma testosterone and LPL activity in postprandial 10 min posthepann plasma (Fig. 4) (21, 54) .
Since steroid hormones do not display major short-term fluctuations in response to feeding, it is unlikely that testosterone alone was responsible for the decrease in LPL activity that took place in the 10-min postheparin plasma fraction over 2 h. If testosterone is involved in the regulation of the postprandial 10-min postheparin plasma enzyme, the hormone would be more likely to have a long-term effect permissive for shortterm regulation. Conceivably, testosterone could control any of the events involved in the regulation of a secretory protein, e.g., synthesis, secretion, and degradation as well as the number of extracellular binding sites for the enzyme.
The notion that human LPL may be regulated by endogenous estrogens as well as androgens requires a comment about hepatic triglyceride lipase. In a number of studies, the latter enzyme measured in postheparin plasma has been shown to be inhibited by exogenous estrogens (22-23, 27, 55) and stimulated by exogenous androgens and progestins (32, 56) . The few studies addressing the effects of endogenous sex steroids on postheparin plasma hepatic triglyceride lipase found suppression of the enzyme during the luteal phase of the menstrual cycle (57) and during pregnancy (58). A negative correlation between estradiol levels and enzyme activity could be demonstrated only in the latter study (58).
In this study, there was no significant correlation between fasting 10 min postheparin plasma hepatic triglyceride lipase activity and either estradiol (r = 0.264; P = 0.341; n = 15) estrone (r = 0.264; P = 0.362; n = 14) or testosterone levels (r = -0.229; P = 0.394; n = 16). Furthermore, there was no significant correlation between hepatic triglyceride lipase activity and any of the parameters of LPL activity in adipose tissue or postheparin plasma presented in this communication (data not shown), making it highly unlikely that any significant part of the hepatic triglyceride lipase was measured as LPL or vice versa. Thus, available data suggest that the hepatic triglyceride lipase is very sensitive to regulation by exogenous sex steroids, perhaps because the oral route ofadministration leads to transiently supranormal hormone concentrations in the hepatic circulation, whereas the role ofendogenous sex steroids is still unclear. By contrast, the reverse situation seems to apply for LPL.
In summary, this study corroborates previous experiments in animals and strongly suggests that estradiol is a major negative regulator of fasting adipose tissue LPL in women, independent of degree of obesity. Together with the finding of a postheparin plasma LPL fraction that is positively correlated to plasma testosterone and probably unrelated to adipose tissue LPL, the present work also hints that both male and female sex steroids may participate in the regulation of LPL in more tissues and to a larger extent than previously thought.
